KR20170028636A - Composition for removing hangover comprising an extract of Allium hookeri - Google Patents
Composition for removing hangover comprising an extract of Allium hookeri Download PDFInfo
- Publication number
- KR20170028636A KR20170028636A KR1020150125486A KR20150125486A KR20170028636A KR 20170028636 A KR20170028636 A KR 20170028636A KR 1020150125486 A KR1020150125486 A KR 1020150125486A KR 20150125486 A KR20150125486 A KR 20150125486A KR 20170028636 A KR20170028636 A KR 20170028636A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- alcohol
- hangover
- present
- composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 206010019133 Hangover Diseases 0.000 title claims abstract description 29
- 241001513212 Allium hookeri Species 0.000 title claims abstract description 13
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims abstract description 25
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims abstract description 25
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims abstract description 24
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 235000013376 functional food Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 210000003494 hepatocyte Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 230000003213 activating effect Effects 0.000 abstract description 3
- 235000019441 ethanol Nutrition 0.000 description 33
- 238000000605 extraction Methods 0.000 description 21
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- -1 olive oil Chemical compound 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000012675 alcoholic extract Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
- C12Y102/01003—Aldehyde dehydrogenase (NAD+) (1.2.1.3)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a hangover to use compositions containing three (Allium hookeri) as active ingredients, three of the present invention (Allium hookeri extract has an effect of activating the action of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) when treated with hepatocytes, and thus the above-mentioned triple extract is useful as a sparingly soluble composition Can be used.
Description
The present invention relates to a composition for hangover decoy comprising Allium hookeri as an active ingredient.
Alcohol is apparently excited when consumed by paralysis of the brain's inhibitory center. It is a major food for modern people who are stressed because of their suppressed consciousness and movement, sleeping and anesthetic effects. In Korea, the consumption of alcohol is continuing to increase with economic growth, and alcohol consumption per capita is the highest in the world. However, alcohol can develop into toxicosis when it is overdosed, and it threatens personal health which damages not only the central nervous system such as the brain but also the digestive organs and metabolic organs such as liver. In addition, the increase in traffic accidents due to drunken driving and the like is a major social problem, and the demand for foods and medicines that can minimize the influence of alcohol on the human body is increasing.
The hangover after drinking is caused by the toxic action of ethyl alcohol or acetaldehyde accumulated in the hepatocytes, and the toxic effect lasts for a long time, resulting in a disorder such as metabolism. Specifically, the normal ethyl alcohol metabolism is absorbed in the gastrointestinal tract or small intestine when ethyl alcohol is introduced into the blood vessels to enter the blood vessels, and the hepatocytes have an alcohol dehydrogenase to oxidize the alcohol to acetaldehyde, It is decomposed into acetic acid by acetaldehyde dehydrogenase in hepatocytes, and it is transferred to muscles and adipose tissues of the whole body and finally decomposed into carbon dioxide gas and water.
Further, the acetaldehyde dehydrogenase has type I, which functions even when acetaldehyde is low in concentration, and type I, which acts only when acetaldehyde is present at a high concentration. However, Asian people generally lack or lack II-type acetaldehyde dehydrogenase Acetaldehyde is not easily decomposed. Therefore, the toxic action of unoxidized acetaldehyde and ethyl alcohol causes damage of hepatocytes and brain cells. In addition, due to the dehydration action of alcohol, various electrolytes are discharged out of the body due to lack of water and moisture in the body, resulting in electrolyte shortage. Due to the above-mentioned causes, normal metabolism is disturbed and various hangover phenomena such as vomiting, headache, chills and stomachache occur.
In order to solve this hangover phenomenon after drinking, a large number of hangover removers which are produced by using alone or in combination with herbal medicines or artificial medicines have been developed. In the private, the Northern countries and bean sprouts soup are frequently used for hangover relief, There is a limit to the use because it is inconvenient to take. Accordingly, there is a demand for development of a hangover remedy which is economical and effective, while solving the above problems.
Allium hookeri are distributed in southern China, India, Bhutan, Sri Lanka, etc. in East Asia and grow in forests, wetlands and grasslands of 1400 m to 4200 m above sea level. It is also called "Root Leek". It is also called "玄 菜" because its taste and shape are similar to ginseng. It is also called "三 菜" because it has three flavors of bitter taste, sweet taste and spicy taste. The height of the plant is about 0.6 to 1 m, and it is known that the roots, leaves and flowers of the three-leafed plants can be used for food and medicinal use.
Korean Patent No. 10-1508215 discloses a composition for whitening and antioxidant containing the extract or a fraction thereof, and Korean Patent No. 10-1441609 discloses a composition for treating a metabolic disease A composition for prevention and treatment has been disclosed. However, no literature disclosing the use of hangover for hangover has been found so far.
Accordingly, the present inventors have studied a hangover remover that activates the action of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) without adverse effects on the human body, and found that a 70% fermented alcohol extract Confirming that the action of the alcohol dehydrogenase and the aldehyde dehydrogenase is activated upon treatment with the hepatocyte HepG2 cell line, thus completing the present invention.
It is an object of the present invention to provide a composition for hangover decoy containing Allium hookeri as an active ingredient.
In order to accomplish the above object, the present invention provides a composition for hangover decoy comprising Allium hookeri as an active ingredient.
Further, the present invention provides a health functional food for hangover marine animals containing Allium hookeri as an active ingredient.
Three of the present invention (Allium hookeri extract of the present invention activates the action of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) when the hepatocyte is treated.
FIG. 1 is a graph showing the effect of an alcohol dehydrogenase (ADH) and an aldehyde dehydrogenase (ALDH) on the activity of trifoliate or root extract.
Hereinafter, the present invention will be described in detail.
The present invention provides a composition for hangover decoy containing Allium hookeri as an active ingredient.
It is preferable, but not limited, to produce the above-mentioned tubular extract by a manufacturing method comprising the following steps:
1) extracting the triplets by adding an extraction solvent;
2) filtering the extract of step 1);
3) Concentrating the filtrate obtained in step 2) under reduced pressure and then drying to prepare a triplex extract.
In the above method, the triplex of step 1) can be used without limitation such as cultivated or marketed, and any of leaves, roots, stems and branches can be used, and the present invention is not limited thereto. It is most preferable to use the leaves of the trifoliate leaves or the leaves of the plants associated with the same.
In the above method, it is preferable that the extraction solvent of step 1) be water, alcohol, alcohol, or a mixture thereof and an organic solvent. Examples of the alcohol include C 1 To C 2 lower alcohol is preferably used, and as the lower alcohol, ethanol or methanol is preferably used. As the extraction method, it is preferable to use shaking extraction, Soxhlet extraction or reflux extraction, but it is not limited thereto. It is preferable that the extraction solvent is added by 1 to 30 times the amount of the trifoliate leaf or root powder, and it is more preferable that the extraction solvent is added by 20 times. The extraction temperature is preferably 20 占 폚 to 100 占 폚, more preferably 20 占 폚 to 40 占 폚, and most preferably room temperature, but is not limited thereto. The extraction time is preferably 10 to 48 hours, more preferably 15 to 30 hours, most preferably 24 hours, but is not limited thereto. The number of times of extraction is preferably 1 to 5 times, more preferably 2 to 4 times, and most preferably, 2 times, but is not limited thereto.
It is preferable that the above-mentioned tubular extract is 40 to 95% alcohol extract, more preferably 50 to 90% alcohol extract, 60 to 80% alcohol extract and most preferably less than 40% May not result in the desired hangover resolution effect, and in the case of the 80% alcohol extract, the production cost of the tubular extract may be increased.
The triple extract is characterized by activating an action of an alcohol dehydrogenase (ADH) and an aldehyde dehydrogenase (ALDH).
In a specific example of the present invention, the present inventors prepared a 70% fermented alcoholic extract using leaf and root portions of a tub, and when the ethanol extract was treated with hepatocyte HepG2 cell line, the above-mentioned tuberous extract was treated with an alcohol dehydrogenase and an aldehyde dehydrogenase (See Fig. 1), the tubular extract of the present invention can be effectively used as a composition for removing hangover.
The composition for sputum hangover of the present invention may further contain one or more active ingredients which exhibit the same or similar functions in addition to the tangerine extract.
The composition for sputum hangover of the present invention can be administered orally or parenterally at the time of clinical administration and can be used in the form of a general pharmaceutical preparation. That is, the composition for sputum hangover of the present invention can be administered in various formulations of oral and parenteral administration at the time of actual clinical administration. In the case of formulation, the filler, the weight agent, the binder, the wetting agent, the disintegrant and the surfactant Diluent or excipient. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose, lactose and gelatin And the like. In addition to simple excipients, lubricants such as magnesium, styrene, and talc may also be used. Liquid preparations for oral administration include suspensions, solutions, emulsions and syrups. Various excipients such as wetting agents, sweetening agents, fragrances and preservatives may be included in addition to commonly used simple diluents such as water and liquid paraffin. have. Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations and suppositories. Examples of the non-aqueous solvent and the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. As the base of the suppository, witepsol, macrogol, tween 61, cacao paper, laurin, glycerol and gelatin can be used. The parenteral composition of the present invention can be administered by subcutaneous injection, intravenous injection, or intramuscular injection.
The preferred dosage of the composition for relieving hangover of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the type of drug, the route of administration and the period of time, but can be appropriately selected by those skilled in the art.
Further, the present invention provides a health functional food for hangover marine animals containing Allium hookeri as an active ingredient.
The above-mentioned tubular extract is preferably prepared by a manufacturing method comprising the following steps, but not limited thereto:
1) extracting the triplets by adding an extraction solvent;
2) filtering the extract of step 1);
3) Concentrating the filtrate obtained in step 2) under reduced pressure and then drying to prepare a triplex extract.
In the above method, the triplex of step 1) can be used without limitation such as cultivated or marketed, and any of leaves, roots, stems and branches can be used, and the present invention is not limited thereto. It is most preferable to use the leaves of the trifoliate leaves or the leaves of the plants associated with the same.
In the above method, it is preferable that the extraction solvent of step 1) be water, alcohol, alcohol, or a mixture thereof and an organic solvent. Examples of the alcohol include C 1 To C 2 lower alcohol is preferably used, and as the lower alcohol, ethanol or methanol is preferably used. As the extraction method, it is preferable to use shaking extraction, Soxhlet extraction or reflux extraction, but it is not limited thereto. It is preferable that the extraction solvent is added by 1 to 30 times the amount of the trifoliate leaf or root powder, and it is more preferable that the extraction solvent is added by 20 times. The extraction temperature is preferably 20 占 폚 to 100 占 폚, more preferably 20 占 폚 to 40 占 폚, and most preferably room temperature, but is not limited thereto. The extraction time is preferably 10 to 48 hours, more preferably 15 to 30 hours, most preferably 24 hours, but is not limited thereto. The number of times of extraction is preferably 1 to 5 times, more preferably 2 to 4 times, and most preferably, 2 times, but is not limited thereto.
It is preferable that the above-mentioned tubular extract is 40 to 95% alcohol extract, more preferably 50 to 90% alcohol extract, 60 to 80% alcohol extract and most preferably less than 40% May not result in the desired hangover resolution effect, and in the case of the 80% alcohol extract, the production cost of the tubular extract may be increased.
The triple extract is characterized by activating an action of an alcohol dehydrogenase and an aldehyde dehydrogenase.
In a specific example of the present invention, the present inventors prepared a 70% fermented alcoholic extract using leaf and root portions of a tub, and when the ethanol extract was treated with hepatocyte HepG2 cell line, the above-mentioned tuberous extract was treated with an alcohol dehydrogenase and an aldehyde dehydrogenase (See Fig. 1), the tubular extract of the present invention can be effectively used as a health functional food for hangover.
The health functional food of the present invention can be used as it is or in combination with other food or food ingredients, and can be suitably used according to conventional methods.
There is no particular limitation on the kind of the health functional food. Examples of the food to which the above-mentioned tangerine-derived extract can be added include dairy products including meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, other noodles, gums, ice cream, soups, drinks, tea, , An alcoholic beverage, and a vitamin complex, all of which include health functional foods in a conventional sense.
The health functional beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 g of the composition of the present invention.
In addition to the above, the health functional food of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusters, stabilizers, Alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such an additive is not critical but is generally selected in the range of 0.01 to 2 parts by weight per 100 parts by weight of the composition of the present invention.
Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples.
However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the content of the present invention is not limited by the following Examples and Experimental Examples.
< Example 1> Triptych Extract preparation
Samcheon was purchased from the morphological evaluation of Sunchang Agricultural Technology Center in Jeollabuk-do, and the leaves were washed with water and freeze-dried (PVTFD 10R, Ilsin Lab, Yangzhou, Korea) Twenty times as much as 70% fermented juice was added to 100 g of the sample, and the mixture was repeatedly stirred twice at room temperature for 24 hours (Jeio tech sk-71, Lab companion, Daejeon, Korea). The extract was filtered using ADVANTEC paper (No. 6) (ADVANTEC Co., Tokyo, Japan), concentrated using a vacuum concentrator (EYELA N-1000, Riakikai Co., Ltd., Tokyo, Japan) Dried and used in the experiment.
< Experimental Example 1> Triptych Extraction of Alcohol Dehydrogenase alcohol dehydrogenase , ADH ) And the activity of aldehyde dehydrogenase (ALDH)
<1-1> Hepatocytes Homogeneous purchase
In order to confirm whether or not the alcohol dehydrogenase and the aldehyde dehydrogenase activity were regulated in the hepatocyte of the tubercle leaf extract prepared by the method of Example 1, a hepatic cell homogenate was obtained in the following manner.
Specifically, the hepatocyte HepG2 (ATCC HB-8065) cell line was inoculated with 10% (v / v) thermally inactivated fetal bovine serum (Gibco, USA) and 1% (v / v) penicillin-streptomycin divides -streptomycin, Gibco, USA) by 1 ㎖ at a rear, a 24-well plate so that the controlled dogs 1 × 10 5 in MEM medium (Gibco, USA) containing the cells were cultured for 24 hours. And, removing the culture medium of a plate culture of the cells, and <Example 1> for 24 hours in a culture medium (control), three leaves and a root extract then added in 1 ㎖, 5% CO 2, conditions of 37 ℃ After removing the extract solution from the plate, 1 ml of 0.25% Trypsin-EDTA (Trypsin-EDTA, Gibco, USA) was added thereto, and the reaction was carried out at 37 ° C for 5 minutes, and hepatocytes were recovered. The recovered hepatocytes were washed once with 0.1 M PBS buffer (Gibco, USA) and centrifuged. The washed cells were mixed with 300 μl of PBS buffer solution, and then 2 mm beads ) Were dispensed into the vial. The vial was homogenized four times for 10 seconds using Fast Prep-24, and centrifuged to obtain a hepatic cell homogenate as a supernatant.
<1-2> Identification of alcohol dehydrogenase and aldehyde dehydrogenase activity
In order to confirm the activity of the alcohol dehydrogenase and the aldehyde dehydrogenase in the liver cell homogenate obtained in the above Experimental Example <1-2>, the analysis was carried out according to the protocol of the manufacturer using the absorbance analysis kit.
Specifically, 50 μl of the hepatocyte homogenate obtained in the above Experimental Example <1-2> was dispensed into 96-wells and mixed with Reacion mix provided in an assay kit (Biovision, USA) using absorbance Then, the reaction was carried out at 37 ° C for 30 minutes and the absorbance at 450 nm was measured. The activity of the alcohol dehydrogenase and the aldehyde dehydrogenase was calculated as shown in FIG. 1 by the following equations (1) and (2).
[Equation 1]
Activity = (ADH or ALDH molar number / reaction time (min) × sample volume (mL)) × dilution factor
&Quot; (2) "
Relative activity = Experimental activity / Control activity × 100
As a result, as shown in Fig. 1, it was confirmed that the leaf and root extracts of the tubers significantly activated the action of the alcohol dehydrogenase and the aldehyde dehydrogenase (Fig. 1).
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150125486A KR20170028636A (en) | 2015-09-04 | 2015-09-04 | Composition for removing hangover comprising an extract of Allium hookeri |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150125486A KR20170028636A (en) | 2015-09-04 | 2015-09-04 | Composition for removing hangover comprising an extract of Allium hookeri |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170180167A Division KR101929350B1 (en) | 2017-12-26 | 2017-12-26 | Composition for removing hangover comprising an extract of Allium hookeri |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20170028636A true KR20170028636A (en) | 2017-03-14 |
Family
ID=58460024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150125486A KR20170028636A (en) | 2015-09-04 | 2015-09-04 | Composition for removing hangover comprising an extract of Allium hookeri |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20170028636A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021187736A1 (en) * | 2020-03-16 | 2021-09-23 | 주식회사 그래미 | Composition for curing hangovers, and healthy food including same |
-
2015
- 2015-09-04 KR KR1020150125486A patent/KR20170028636A/en active Search and Examination
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021187736A1 (en) * | 2020-03-16 | 2021-09-23 | 주식회사 그래미 | Composition for curing hangovers, and healthy food including same |
| KR20210115691A (en) * | 2020-03-16 | 2021-09-27 | 주식회사 그래미 | Composition for removing Hangover and health functional food comprising the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101929350B1 (en) | Composition for removing hangover comprising an extract of Allium hookeri | |
| CN101365671B (en) | Isohumulone compound clathrate and composition containing the same | |
| JP6682073B2 (en) | Liver function improver | |
| KR101483592B1 (en) | Decreasing Effect in Blood Ethanol Concentration and Improvement of Hepatic Function Including Preparation of Sprouts Hordeum Vulgare Extracts | |
| KR101490786B1 (en) | Composition comprising water extracts from fomitella fraxinea (fr.) imaz. for treating or preventing obesity | |
| JP2015149918A (en) | beverage | |
| US20180103670A1 (en) | Composition, drink, method of production and use thereof | |
| KR102180223B1 (en) | Anti-obesity composition comprising extract of Sargassum horneri | |
| EP1718167A1 (en) | Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof | |
| KR101682916B1 (en) | Composition comprising steamed and fermented Lycium chinense extract with increased anti-inflammatory or antioxidant activity and preparation method thereof | |
| JP2020063302A (en) | Liver function improver | |
| KR101692889B1 (en) | Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases | |
| KR20210002378A (en) | Hepatoprotective composition containing pini pollen extract as effective component | |
| KR20170028636A (en) | Composition for removing hangover comprising an extract of Allium hookeri | |
| KR101344055B1 (en) | Composition for improving liver function containing fermented liquor of Codonopsis lanceolata extract as effective component | |
| KR20200053016A (en) | Pharnaceutical composition for prevention or treatment of diabetes comprising the mixed extract of vegetable natural products having the effect on removal of swelling and health functional food for prevention or improvement of diabetes comprising the same | |
| KR101358197B1 (en) | Composition for promoting leptin secretion comprising specific compounds as effective component | |
| JP6718158B2 (en) | Liver function improver | |
| KR100919134B1 (en) | Extract of antiobestic ginseng with anti-obesity effect comprising high concentration of less polar ginsenoid and method of preparing the same | |
| CN109619577A (en) | The application of Rosa roxburghii Tratt water extract | |
| KR101490794B1 (en) | Composition comprising alcohol extracts from oligoporus tephroleucus for treating or preventing hyperlipidemia | |
| KR101964837B1 (en) | Composition for improving skin wrinkle comprising Cynomorium songaricum extract or its fraction as effective component | |
| KR101622032B1 (en) | Pharmaceutical composition comprising Cymbidium extract for preventing or treating muscle atrophy | |
| JP7320270B2 (en) | Liver function improver | |
| KR102290222B1 (en) | Composition for preventing or treating nonalcoholic fatty liver disease comprising extract of Rubus coreanus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E601 | Decision to refuse application | ||
| AMND | Amendment |